Canadian Sec - Delayed Quote CAD

Isracann Biosciences Inc. (IPOT.CN)

0.0150 0.0000 (0.00%)
At close: April 5 at 10:41 AM EDT
Key Events
Loading Chart for IPOT.CN
DELL
  • Previous Close 0.0150
  • Open 0.0000
  • Bid 0.0100 x --
  • Ask 0.0250 x --
  • Day's Range 0.0150 - 0.0150
  • 52 Week Range 0.0150 - 0.0150
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 2.64M
  • Beta (5Y Monthly) 0.03
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.

www.isracann.com

--

Full Time Employees

--

Fiscal Year Ends

Related News

Performance Overview: IPOT.CN

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IPOT.CN
0.00%
S&P/TSX Composite index
4.82%

1-Year Return

IPOT.CN
0.00%
S&P/TSX Composite index
7.48%

3-Year Return

IPOT.CN
95.00%
S&P/TSX Composite index
15.01%

5-Year Return

IPOT.CN
96.00%
S&P/TSX Composite index
32.54%

Compare To: IPOT.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IPOT.CN

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -0.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -34.99%

  • Return on Equity (ttm)

    -252.75%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -4.54M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    198.05k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -567.05k

Company Insights: IPOT.CN